ENG Gene Variant rs1064795636: Understanding HHT Associations

What each genotype means

What is the rs1064795636 Variant?

The rs1064795636 variant is a specific change in the DNA sequence of the ENG gene. In genomics, an rsID (reference SNP cluster ID) acts as a unique identifier for a particular location in the human genome where a single nucleotide polymorphism (SNP) or other small variation may occur. This variant sits within the ENG gene, which is located on chromosome 9. Because the human genome is vast, researchers use these identifiers to track specific positions across different studies and databases. When a variant is identified in a gene like ENG, scientists investigate whether that change alters the function of the protein the gene encodes. For rs1064795636, the focus of research has been its potential role in the development of vascular conditions, specifically hereditary hemorrhagic telangiectasia (HHT). Understanding the location and nature of this variant is the first step in determining how it might influence biological processes in the body.

The Role of the ENG Gene

The ENG gene is essential for the production of a protein called endoglin. Endoglin is primarily found on the surface of endothelial cells, which are the cells that line the interior of blood vessels. This protein plays a critical role in the signaling pathways that regulate the growth, proliferation, and stability of blood vessels, a process known as angiogenesis. By helping to manage how blood vessels form and maintain their structure, endoglin ensures that the circulatory system functions correctly. When the ENG gene contains a pathogenic variant, the resulting endoglin protein may be non-functional or produced in insufficient quantities. This disruption can lead to the formation of fragile, abnormal blood vessels. These vessels, known as telangiectases or arteriovenous malformations (AVMs), are the hallmark of HHT. Because the ENG gene is so vital for vascular integrity, variations within it are closely monitored by clinical geneticists to understand their impact on patient health.

Research and Evidence Strength

The association between variants in the ENG gene and hereditary hemorrhagic telangiectasia is well-established in medical literature. HHT is an autosomal dominant disorder, meaning that a single copy of a pathogenic variant—inherited from either parent—is typically sufficient to cause the condition. Research into rs1064795636 is grounded in the broader understanding that mutations in ENG are a primary cause of HHT type 1. While the evidence linking the ENG gene to HHT is definitive, the specific clinical impact of any single variant, such as rs1064795636, can vary. Scientists use databases like ClinVar and the GWAS Catalog to aggregate data on how these variants correlate with clinical symptoms. It is important to note that even within families carrying the same variant, the severity and location of vascular malformations can differ significantly. This phenotypic variability remains a subject of ongoing research, as scientists work to understand why the same genetic change manifests differently among individuals.

Population Frequency and Prevalence

The rs1064795636 variant is classified as rare in the general population. Genomic databases like gnomAD are used to estimate the frequency of such variants across diverse ancestral groups. Because HHT itself is a rare condition, the variants that cause it are also expected to be found at low frequencies. Current research suggests that the prevalence of HHT-associated variants is estimated to be roughly 4.4 in 5000 individuals, though this figure is subject to refinement as more large-scale genomic data becomes available. The rarity of this variant means that it is not commonly found in the general population, and its presence is usually investigated in the context of a clinical evaluation for HHT. If you have received information about this variant from a genetic test, it is important to interpret this in the context of your personal and family medical history, as population-level statistics provide only a broad overview of frequency rather than individual risk.

Navigating Genetic Information

If you have identified the rs1064795636 variant in your genetic data, it is essential to approach this information with care. Genetic testing results can be complex, and the presence of a variant does not automatically equate to a clinical diagnosis of HHT. HHT is typically diagnosed based on clinical criteria, such as the presence of recurrent nosebleeds, telangiectases, and visceral AVMs. A genetic variant is one piece of a larger diagnostic puzzle. You cannot use this information to self-diagnose or make medical decisions. If you are concerned about your results, the most appropriate step is to consult with a genetic counselor or a physician who specializes in vascular disorders. They can help you understand the clinical significance of the variant, discuss the implications for your family members, and determine if further clinical screening is necessary. Always rely on professional medical guidance rather than online databases when interpreting your personal genetic health information.

Frequently asked questions

Sources & further reading

Related variants in ENG